Market cap
$136 Mln
Revenue (TTM)
$300 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
136 | 8,703 | 6,839 | 5,419 | 630 |
Revenue ($ Mln) |
300 | 6,785 | 18,330 | 1,109 | 1,165 |
Net Profit ($ Mln) |
-40.85 | 845.55 | 320.40 | 170.85 | 56.38 |
Net Margin (%) |
-13.64 | 12.46 | 1.75 | 15.41 | 4.84 |
RoE (%) |
-21.62 | 34.41 | 8.44 | 13.08 | 14.87 |
Price to Earnings |
-- | 14.87 | 21.43 | 32.13 | 11.28 |
Price-To-Book |
0.76 | 1.67 | 1.76 | 4.08 | 1.70 |
Income Statement ($ Mln)
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
299.57 | 6,784.87 | 18,329.91 | 1,108.98 | 1,165.13 |
|
Cost of Revenue
|
92.24 | 5,062.58 | 16,882.40 | 704.60 | 959.14 |
|
Gross Profit
|
275.19 | 969.46 | 2,358.14 | 370.63 | 203.47 |
|
Operating Expenses
|
239.92 | 620.76 | 820.62 | 167.03 | 126.72 |
|
Operating Profit (EBIT)
|
-32.58 | 1,101.53 | 626.88 | 237.35 | 79.27 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-29.15 | 1,068.57 | 488.64 | 220.38 | 75.49 |
|
Provision for Tax
|
11.70 | 215.05 | 169.72 | 49.53 | 19.11 |
|
Profit after Tax (Net Income)
|
-40.85 | 845.55 | 320.40 | 170.85 | 56.38 |
|
Minority Interest
|
0.00 | -6.64 | 0.19 | 0.00 | 0.00 |
|
Consolidated Profit
|
-18.12 | 56.94 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
180.28 | 0.00 | 3,875.62 | 1,326.78 | 370.78 |
|
Minority Interest
|
0.00 | -6.64 | 0.19 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
17.61 | 0.00 | 4,159.33 | 212.68 | 129.22 |
|
Current Liabilities
|
41.88 | 0.00 | 2,889.21 | 164.12 | 173.02 |
|
Total Liabilities
|
257.01 | 10,298.78 | 10,343.53 | 1,707.56 | 597.60 |
Assets ($ Mln)
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
37.83 | 2,831.70 | 6,470.08 | 1,298.70 | 56.37 |
|
Current Assets
|
201.94 | 121.72 | 4,466.34 | 404.88 | 326.35 |
|
Total Assets
|
257.01 | 10,298.78 | 10,343.53 | 1,707.56 | 597.60 |
|
Total Debt*
|
20.69 | 0.00 | 3,661.89 | 142.44 | 43.03 |
|
Net Current Assets
|
160.06 | 0.00 | 0.00 | 240.76 | 166.28 |
Cashflow ($ Mln)
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
6.86 | 1,059.72 | 1,371.65 | 216.56 | 30.55 |
|
Cash Flow from Investing Activities
|
-7.93 | -720.28 | -705.51 | -43.89 | -50.82 |
|
Cash from Financing Activities
|
-0.56 | -337.89 | -2,113.00 | -152.81 | 20.38 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-8.45 | 0.72 | 14.69 | 11.03 | 14.06 |
|
ROE (%)
|
-21.62 | 34.41 | 8.44 | 13.08 | 14.87 |
|
ROA (%)
|
-13.70 | 11.63 | 2.28 | 9.35 | 7.19 |
|
EBIT Margin (%)
|
-10.24 | 15.63 | 3.53 | 20.40 | 6.75 |
|
Net Margin (%)
|
-13.64 | 12.46 | 1.75 | 15.41 | 4.84 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-30.28 | 16.25 | -0.12 | 9.42 | 3.13 |
|
EBIT Growth (%)
|
-1,619.17 | 237.66 | -63.51 | 10.70 | -13.76 |
|
Net Profit Growth (%)
|
-16,572.58 | 684.57 | -73.96 | 14.51 | -14.58 |
|
EPS Growth (%)
|
-17,707.96 | 687.47 | -74.00 | 16.26 | -14.97 |
|
Book Value Growth (%)
|
-17.46 | -- | 9.19 | 4.37 | 1.33 |
Valuation Ratios
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-6.29 | 91.95 | 8.59 | 32.01 | 12.59 |
|
Price / Book Value
|
0.59 | 1.22 | 2.53 | 3.94 | 2.06 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-3.85 | 12.42 | 5.67 | 19.90 | 7.47 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.88 | 0.00 | 0.09 | 0.12 |
|
Short term debt to equity ratio
|
0.02 | 0.03 | 0.00 | 0.00 | 0.19 |
|
Current Ratio
|
4.82 | 1.50 | 1.55 | 2.47 | 1.89 |
|
Quick Ratio
|
4.32 | 0.99 | 0.83 | 1.39 | 0.53 |
|
Interest Coverage
|
-- | 4.29 | 4.08 | 26.46 | 36.47 |
Operating Efficiency Ratios
| MEDIFAST INC (MED) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | John B Sanfilippo & Son Inc (JBSS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.00 | 0.00 | 5.52 | 13.13 | 7.66 |
|
Asset Turnover
|
1.00 | 0.93 | 1.31 | 0.61 | 1.49 |
|
Receivable days
|
-- | 37.99 | 23.31 | 46.35 | 26.68 |
|
Inventory Days
|
103.45 | 39.01 | 43.17 | 71.86 | 91.17 |
|
Payable days
|
62.94 | 25.42 | 30.21 | 31.56 | 23.02 |
|
Cash Conversion Cycle
|
-- | 51.58 | 36.27 | 86.65 | 94.83 |